Funding

[Funding alert] OrbiMed Raises $4.3 Billion Across Private Investment Funds

Oct 25, 2023 | By Startup Rise EU

OrbiMed Raises $4.3 Billion across private investment funds including OrbiMed Private Investments IX, OrbiMed Asia Partners V and OrbiMed Royalty & Credit Opportunities IV.

OrbiMed Raises $4.3 Billion across private investment funds including OrbiMed Private Investments IX, OrbiMed Asia Partners V and OrbiMed Royalty & Credit Opportunities IV.

Consistent with their predecessors, these new funds enable OrbiMed to invest globally, from seed stage for start-ups incubated by OrbiMed through growth capital opportunities.

OrbiMed works closely with its portfolio companies to provide tailored financing solutions, which can include equity, credit and royalty-based financing.

Read also - Stockholm-based Hailey HR Raises €1.7 million in Funding

RECOMMENDED FOR YOU

recomd
Funding
Apolitical Funding News – Apolitical Raises $5 Mn Grant From Google.org to Train one Million Civil Servants in AI
Team SR
Jun 19, 2024
recomd
Funding
[Funding alert] Paris-based Pivot Secures €20 Million in Funding
Startup Rise EU
Dec 13, 2023
recomd
Funding
[Funding alert] Ukraine-based Hackless Secures $1.2M in Funding
Startup Rise EU
Dec 16, 2023

OrbiMed focuses on innovative and growth-oriented opportunities across healthcare sub-sectors, including biopharmaceuticals, medical devices, diagnostics and technologyenabled healthcare services.

OrbiMed is led by its 21 partners, with a growing team exceeding 130 professionals that contribute diverse, complementary skills across company incubation, strategy, operations and finance.

Read also - Munich-based Lanes & Planes Secures $35 Million in Series B Round Funding

The firm’s professionals are based in a dozen global locations across key healthcare markets in North America, Europe and Asia. Investors in these new funds include a broad range of medical institutions, university endowments, foundations, pension funds, sovereign wealth funds and family offices.

Carter Neild, a Managing Partner of OrbiMed said, “OrbiMed is deeply appreciative of the continued support we’ve received from many long-standing partners who’ve invested in these funds, We will endeavor to meet our partners’ high expectations in the coming years.”

About OrbiMed

OrbiMed is a leading healthcare investment firm with more than $17 billion in assets under
management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds and royalty/credit funds.

Read also - UK-based Kao Data has Funding from Legal & General Capital and Infratil

OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies.

Recommended Stories for You

story
Recent Articles

[Funding alert] London-based Fintech Startup SumUp Secures €285 Million in Funding

Startup Rise EU Dec 11, 2023

story
Norway

Iris.ai funding news – Oslo-based Iris.ai Secures €7.64 Million in Funding

Startup Rise EU May 29, 2024

story
Funding

[Funding alert] Zurich-based Health Tech Startup Care Secures an Investment from NHL Player Kevin Fiala

Startup Rise EU Nov 6, 2023

story
Funding

[Funding alert] Modena-based Axyon AI Secures €3.9Million in Funding

Startup Rise EU Jan 26, 2024

story
France

[Funding alert] French-based Legal AI Company Jimini AI Secures €1.9 Million in Seed Funding

Startup Rise EU Nov 13, 2023

story
Funding

[Funding alert] Zurich-based Gen Z Recruiting Startup CareerFairy Secures €3.5 Million in Funding

Startup Rise EU Dec 19, 2023